TCF12 and neoplasm: Restricting the analysis to tumours with the TCF12-altered bHLH domain (n=6), we found downregulation of pathways featuring known partners of TCF12, such as TCF21, EZH2 and BMI1 (ref. 18) (Supplementary Table 2).